Table 3.

Classification of congenital thrombocytopenias including gene defect, inheritance, and associated features.

InheritedThrombocytopeniasAbbre-viationGene(Localization)InheritedPatternClinical and Laboratory Features
Wiskott-Aldrich syndrome WAS WAS (Xp11) X-L Severe immunodeficiency.
 Defective WAS protein.
 Small platelets. Eczema. 
X-linked thrombocytopenia XLT WAS (Xp11) Exon2 X-L Mild immunodeficiency. Defective WAS protein. Small platelets. 
Familial platelet disorder with 
 predisposition to acute 
 myelogenous leukemia FPD/AML CBFA2 (21q22) AD Propensity to develop myelodysplastic
 syndrome or acute myelogenous leukemia.
 Normal platelet size. Dysfunctional platelets. 
Amegakaryocytic thrombocytopenia CAMT c-Mpl (1p34) AR Hypomegakaryocytic thrombocytopenia
 evolving into bone marrow aplasia.
 Normal platelet size. 
Amegakaryocytic thrombocytopenia 
 with radio-ulnar synostosis CTRUS HOXA11 (7p15-14) AD Reduced-absent megakaryocytes.
 Radio-ulnar synostosis ± other malformations.
 Possible sensorineural hearing loss.
 Normal platelet size. 
Thrombocytopenia with absent radii TAR n.d. AR Thrombocytopenia usually severe in the first
 year of life. Reduced megakaryocytes.
 Bilateral radial aplasia ± other malformations.
 Normal platelet size. 
Bernard-Soulier syndrome BSS GPIbα (17p13) 
 GPIbβ (22q11) 
 GPIX (3q21) AD Defective GPIb/IX/V. 
 Homozygous subjects: defective ristocetin-
 induced platelet agglutination. Giant platelets. 
 Heterozygous subjects: mild thrombocyto-
 penia, normal ristocetin-induced platelet
 agglutination. Large platelets. 
Velocardiofacial syndrome/DiGeorge VCFS 1q22, 10 p4 AD Right heart defect. Palate defect. T cell
 immune deficiency. Evans syndrome.
 Large platelets. 
Von Willebrand disease type 2B
 Platelet type von Willebrand disease VW2B
 PltVWF GP1bα (17p13) AD
 AD Platelet clumping. Abnormal (hyperreactive)
 ristocetin-induced platelet agglutination. 
Benign Mediterranean 
 macrothrombocytopenia n.d. n.d. AD Dysmegakaryocytopoiesis. Large platelets. 
X-linked thrombocytopenia and 
 dyserythropoiesis with or 
 without anemia
 X-linked thrombocytopenia-
 thalassemia XLTT GATA-1 (Xp11) X-L Anemia (mild to nil), unbalanced globin chain
 synthesis resembling β-thalassemia,
 peripheral red cell hemolysis,
 dysmegakaryocytopoiesis, splenomegaly.
 Large platelets. 
MYH9-related disease 
    May-Hegglin anomaly MHA MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss, cataract
 and/or renal defect. Giant platelets. 
    Sebastian syndrome SBS MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss ±
 cataract ± renal defect. Giant platelets. 
    Fechtner syndrome FTNS MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss ±
 cataract ± renal defect. Giant platelets. 
    Epstein syndrome EPTS MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss ±
 cataract ± renal defect. Giant platelets. 
Gray platelet syndrome GPS n.d. AD Pale platelets on blood films due to reduced-
 absent α-granules. Large platelets. 
InheritedThrombocytopeniasAbbre-viationGene(Localization)InheritedPatternClinical and Laboratory Features
Wiskott-Aldrich syndrome WAS WAS (Xp11) X-L Severe immunodeficiency.
 Defective WAS protein.
 Small platelets. Eczema. 
X-linked thrombocytopenia XLT WAS (Xp11) Exon2 X-L Mild immunodeficiency. Defective WAS protein. Small platelets. 
Familial platelet disorder with 
 predisposition to acute 
 myelogenous leukemia FPD/AML CBFA2 (21q22) AD Propensity to develop myelodysplastic
 syndrome or acute myelogenous leukemia.
 Normal platelet size. Dysfunctional platelets. 
Amegakaryocytic thrombocytopenia CAMT c-Mpl (1p34) AR Hypomegakaryocytic thrombocytopenia
 evolving into bone marrow aplasia.
 Normal platelet size. 
Amegakaryocytic thrombocytopenia 
 with radio-ulnar synostosis CTRUS HOXA11 (7p15-14) AD Reduced-absent megakaryocytes.
 Radio-ulnar synostosis ± other malformations.
 Possible sensorineural hearing loss.
 Normal platelet size. 
Thrombocytopenia with absent radii TAR n.d. AR Thrombocytopenia usually severe in the first
 year of life. Reduced megakaryocytes.
 Bilateral radial aplasia ± other malformations.
 Normal platelet size. 
Bernard-Soulier syndrome BSS GPIbα (17p13) 
 GPIbβ (22q11) 
 GPIX (3q21) AD Defective GPIb/IX/V. 
 Homozygous subjects: defective ristocetin-
 induced platelet agglutination. Giant platelets. 
 Heterozygous subjects: mild thrombocyto-
 penia, normal ristocetin-induced platelet
 agglutination. Large platelets. 
Velocardiofacial syndrome/DiGeorge VCFS 1q22, 10 p4 AD Right heart defect. Palate defect. T cell
 immune deficiency. Evans syndrome.
 Large platelets. 
Von Willebrand disease type 2B
 Platelet type von Willebrand disease VW2B
 PltVWF GP1bα (17p13) AD
 AD Platelet clumping. Abnormal (hyperreactive)
 ristocetin-induced platelet agglutination. 
Benign Mediterranean 
 macrothrombocytopenia n.d. n.d. AD Dysmegakaryocytopoiesis. Large platelets. 
X-linked thrombocytopenia and 
 dyserythropoiesis with or 
 without anemia
 X-linked thrombocytopenia-
 thalassemia XLTT GATA-1 (Xp11) X-L Anemia (mild to nil), unbalanced globin chain
 synthesis resembling β-thalassemia,
 peripheral red cell hemolysis,
 dysmegakaryocytopoiesis, splenomegaly.
 Large platelets. 
MYH9-related disease 
    May-Hegglin anomaly MHA MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss, cataract
 and/or renal defect. Giant platelets. 
    Sebastian syndrome SBS MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss ±
 cataract ± renal defect. Giant platelets. 
    Fechtner syndrome FTNS MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss ±
 cataract ± renal defect. Giant platelets. 
    Epstein syndrome EPTS MYH9 (22q12-13) AD Neutrophil inclusions ± hearing loss ±
 cataract ± renal defect. Giant platelets. 
Gray platelet syndrome GPS n.d. AD Pale platelets on blood films due to reduced-
 absent α-granules. Large platelets. 

or Create an Account

Close Modal
Close Modal